8 Einträge gefunden

1. Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

   1. Wiegel, Thomas
   2. Albers, Peter
   3. Bartkowiak, Detlef
   4. Bussar-Maatz, Roswitha
   5. Härter, Martin
   6. Kristiansen, Glen
   7. Martus, Peter

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

   1. Wiegel, Thomas
   2. Albers, Peter
   3. Bartkowiak, Detlef
   4. Bussar-Maatz, Roswitha
   5. Härter, Martin
   6. Kristiansen, Glen
   7. Martus, Peter

   2021 - Forschungsinformationssystem des UKE
3. Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial

   1. Albers, Peter
   2. Wiegel, Thomas
   3. Schmidberger, Heinz
   4. Bussar-Maatz, Roswitha
   5. Härter, Martin
   6. Kristiansen, Glen
   7. Martus, Peter

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re:results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

   1. Wiegel, Thomas
   2. Albers, Peter
   3. Bartkowiak, Detlef
   4. Bussar-Maatz, Roswitha
   5. Härter, Martin
   6. Kristiansen, Glen
   7. Martus, Peter

   2021 - Forschungsinformationssystem des UKE
5. Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial

   1. Dietzsch, Stefan
   2. Placzek, Felix
   3. Pietschmann, Klaus
   4. von Bueren, André O
   5. Matuschek, Christiane
   6. Glück, Albrecht
   7. Guckenberger, Matthias

   2020 - Forschungsinformationssystem des UKE
6. Radiochemotherapy with or without cetuximab for unresectable esophageal cancer:final results of a randomized phase 2 trial (LEOPARD-2)

   1. Rades, Dirk
   2. Bartscht, Tobias
   3. Hunold, Peter
   4. Schmidberger, Heinz
   5. König, Laila
   6. Debus, Jürgen
   7. Belka, Claus

   2020 - Forschungsinformationssystem des UKE
7. Hodenkarzinom

   1. Winter, Christian
   2. Rabenalt, Robert
   3. Albers, Peter
   4. Bokemeyer, Carsten
   5. Panse, Jens
   6. Schmidberger, Heinz

   2011 - Forschungsinformationssystem des UKE
8. Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society.

   1. Heidenreich, Axel
   2. Albers, Peter
   3. Classen, Johannes
   4. Graefen, Markus
   5. Gschwend, Jürgen
   6. Kotzerke, Jörg
   7. Krege, Susanne

   2010 - Forschungsinformationssystem des UKE